©2024 Cognivue, Inc. | Privacy Policy | References
- Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., Orgeta, V., … Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England), 396(10248), 413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
- Galvin JE, et al. Bridging the Assessment Gap: Newly Developed Neuropsychiatric Cognitive Assessments on the Cognivue Platform Show Strong Correlation with Traditional Gold Standard Tests. Poster presented at: the Clinical Trials for Alzheimer’s Disease (CTAD) Annual Conference; October 24-27, 2023; Boston, MA.
- Alzheimer’s Disease Facts and Figures. Alzheimer’s Association. Accessed 5/30/2023
- Hearing Loss Facts and Statistics. Hearing Loss Association of America. Accessed 5/30/2023
- Bai, W., Chen, P., Cai, H., Zhang, Q., Su, Z., Cheung, T., Jackson, T., Sha, S., & Xiang, Y. T. (2022). Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age and ageing, 51(8), afac173. https://doi.org/10.1093/ageing/afac173
- ADI – Dementia statistics. (n.d.). ADI – Dementia Statistics. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/
- Cahn-Hidalgo, D., Estes, P. W., & Benabou, R. (2020). Validity, reliability, and psychometric properties of a computerized, cognitive assessment test (Cognivue®). World journal of psychiatry, 10(1), 1–11. DOI: https://doi.org/10.5498/wjp.v10.i1.1
- Andrefsky J., Cahn-Hidalgo D., Benabou R, et al. (2020) Superior Test-Retest Reliability of Cognitive Assessment with Cognivue® vs Slums During an 18-Month Longitudinal Study, Neurol Sci Neurosurg, Volume 2:1. 114. DOI: https://doi.org/10.47275/2692-093X-114
- Ma F., Hashmi A., Liu C.Y., et al. (2022) Cognitive Stressors and COVID-19 Infection: A Longitudinal Survey. Neurol Sci Neurosurg, Volume 3:1. 119. DOI: https://doi.org/10.47275/2692-093X-119
- Ma F., Cahn-Hidalgo D. (2021) Clinical Validation of Cognivue® – A Computerized Alternative to the Montreal Cognitive Assessment Test. Neurol Sci Neurosurg, Volume 2:2. 116. DOI: https://doi.org/10.47275/2692-093X-116
- Ma F., Hashmi A., Liu C.Y. (2020) COVID-19-Related Stressors and the Role of Cognitive Assessment, Neurol Sci Neurosurg, Volume 2:1. 115. DOI: https://doi.org/10.47275/2692-093X-115
- Bomprezzi R., Ararat K., Eleftheriou E. (2020) Cognitive Impairment in Patients with Multiple Sclerosis as Assessed by Objective Computerized Testing, Neurol Sci Neurosurg, Volume 2:1. 113. DOI: https://doi.org/10.47275/2692-093X-113.
- Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., Cooper, C., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Larson, E. B., Ritchie, K., Rockwood, K., Sampson, E. L., Samus, Q., … Mukadam, N. (2017). Dementia prevention, intervention, and care. Lancet (London, England), 390(10113), 2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6
- Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
- Lin, F. R., Yaffe, K., Xia, J., Xue, Q. L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., & Health ABC Study Group (2013). Hearing loss and cognitive decline in older adults. JAMA internal medicine, 173(4), 293–299. https://doi.org/10.1001/jamainternmed.2013.1868
- Fortunato, S., Forli, F., Guglielmi, V., De Corso, E., Paludetti, G., Berrettini, S., & Fetoni, A. R. (2016). A review of new insights on the association between hearing loss and cognitive decline in ageing. Acta otorhinolaryngologica Italica 36(3), 155–166. https://doi.org/10.14639/0392-100X-993
- Beck D.L., Grisel J.J. (2022) Cognitive screenings in otolaryngology? The time has come. J Otolaryngol ENT Res.14(2):56‒60. DOI: 10.15406/joentr.2022.14.00507
- Beck D.L. (2022) The emerging relationship between cognition and audition: why cognitive screenings are beneficial for audiology patients and why comprehensive audiometric evaluations are recommended for people with mild cognitive impairment, cognitive decline and dementia. J Otolaryngol ENT Res. 14(1):1‒6. DOI: 10.15406/joentr.2022.14.00496
- Beck D.L., Bant S., Clarke N.A. (2020) Hearing loss and cognition: a discussion for audiologists and hearing healthcare professionals. J Otolaryngol ENT Res. 12(3):72‒78. DOI: 10.15406/joentr.2020.12.00459
- Rawle, M. J., Cooper, R., Kuh, D., & Richards, M. (2018). Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. Journal of the American Geriatrics Society, 66(5), 916–923. https://doi.org/10.1111/jgs.15317
- Loggia, G., Attoh-Mensah, E., Pothier, K., Morello, R., Lescure, P., Bocca, M. L., Marcelli, C., & Chavoix, C. (2020). Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility. Frontiers in pharmacology, 10, 1659. https://doi.org/10.3389/fphar.2019.01659
- Vetrano, D. L., Villani, E. R., Grande, G., Giovannini, S., Cipriani, M. C., Manes-Gravina, E., Bernabei, R., & Onder, G. (2018). Association of Polypharmacy With 1-Year Trajectories of Cognitive and Physical Function in Nursing Home Residents: Results From a Multicenter European Study. Journal of the American Medical Directors Association, 19(8), 710–713. https://doi.org/10.1016/j.jamda.2018.04.008
- Langeard, A., Pothier, K., Morello, R., Lelong-Boulouard, V., Lescure, P., Bocca, M. L., Marcelli, C., Descatoire, P., & Chavoix, C. (2016). Polypharmacy Cut-Off for Gait and Cognitive Impairments. Frontiers in pharmacology, 7, 296. https://doi.org/10.3389/fphar.2016.00296
- American Psychological Association.2019 Phsychological and Neuropsychological Testing CPT® Codes, Descriptions & Total RVUs. Available:https://www.apaservices.org/practice/reimbursement/health-codes/psychological-neuropsychological-codes.pdf. Accessed May 16, 2019.
- Magellan Health, Inc. 2019 CPT® Coding Changes for Psychological and Neuropsychological Testing Background and Frequently Asked Questions. Available:https://www.magellanprovider.com/media/95403/psych-testing-coding-changes-faq.pdf. Accessed December 21, 2018
- MediCal Psychological Services. Allied Health – Psychological Services 519. December 2018. Available: https://files.medical.ca.gov/pubsdoco/publications/mastersmtp/part2/psychol_a07.doc. Accessed June 27, 2019.
- Tufts Health Plan. Medical Necessity Guidelines: Neuropsychological Testing and Assessment. January 2019. Available: https://tuftshealthplan.com/documents/providers/guidelines/medical-necessityguidelines/neuropsych-testing. Accessed June 27, 2019
- Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. The Lancet 2023; published online July 18. Available: https://doi.org/10.1016/S0140-6736(23)01406-X.
- Galvin JE, Velocity Clinical Research, et al. Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding Study (FOCUS). Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 16-20, 2023; Amsterdam.
- Abubaka A, Kabisatpathy S, Lutz S, Sinclair J. Community Pharmacists Expand Access to Cognitive Function Assessments with the Cognivue Clarity® Device. Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 16-20, 2023; Amsterdam.
- Galvin JE, Raskin J, et al. Advancing Computerized Cognitive Assessment with Cognivue: Enhanced Normative Range Data Sets from a Diverse Population Improve Sensitivity and Patient Profiling. Poster presented at: the Clinical Trials for Alzheimer’s Disease (CTAD) Annual Conference; October 24-27, 2023; Boston, MA.
- Montgomery B, et al. Comparing a Comprehensive Neuropsychological Battery Diagnosis to a Diagnosis Given by a Brief Computerized Assessment Tool. Poster presented at: the International Neuropsychological Society Meeting (INS); February 14-17, 2024; New York.
- Nicolas DM, et al. Correlation Between Learning and Memory Performance on a Computerized Cognitive Assessment and a Pencil-and-Paper Traditional Neuropsychological Measure. Poster presented at: the International Neuropsychological Society Meeting (INS); February 14-17, 2024; New York.
- Galvin JE, et al. Cognivue Clarity® in the Detection of Biomarker-Confirmed Mild Cognitive Impairment and Alzheimer’s Disease. Poster presented at: the American Academy of Neurology (AAN) Annual Meeting; April 13-18, 2024; Denver.
- Galvin JE, Chang LC, Estes PW, et al. Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population. J Alzheimers Dis. 2024;100(2):509-523. doi: 10.3233/JAD-240331. PMID: 38875043.
- Galvin JE, et al. Detection of Amyloid Status and Preclinical Alzheimer’s Disease Using Cognivue Clarity®, An Adaptive Psychophysics Computerized Cognitive Battery in The Bio-Hermes Study. Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 28-August 1, 2024; Philadelphia.
- Livingston G, Huntley J, Liu K, et al. (2024). Dementia Prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 404(10452), 572-628. DOI: 10.1016/S0140-6736(24)01296-0.
- Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., Orgeta, V., … Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England), 396(10248), 413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
- Galvin JE, et al. Bridging the Assessment Gap: Newly Developed Neuropsychiatric Cognitive Assessments on the Cognivue Platform Show Strong Correlation with Traditional Gold Standard Tests. Poster presented at: the Clinical Trials for Alzheimer’s Disease (CTAD) Annual Conference; October 24-27, 2023; Boston, MA.
- Alzheimer’s Disease Facts and Figures. Alzheimer’s Association. Accessed 5/30/2023
- Hearing Loss Facts and Statistics. Hearing Loss Association of America. Accessed 5/30/2023
- Bai, W., Chen, P., Cai, H., Zhang, Q., Su, Z., Cheung, T., Jackson, T., Sha, S., & Xiang, Y. T. (2022). Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age and ageing, 51(8), afac173. https://doi.org/10.1093/ageing/afac173
- ADI – Dementia statistics. (n.d.). ADI – Dementia Statistics. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/
- Cahn-Hidalgo, D., Estes, P. W., & Benabou, R. (2020). Validity, reliability, and psychometric properties of a computerized, cognitive assessment test (Cognivue®). World journal of psychiatry, 10(1), 1–11. DOI: https://doi.org/10.5498/wjp.v10.i1.1
- Andrefsky J., Cahn-Hidalgo D., Benabou R, et al. (2020) Superior Test-Retest Reliability of Cognitive Assessment with Cognivue® vs Slums During an 18-Month Longitudinal Study, Neurol Sci Neurosurg, Volume 2:1. 114. DOI: https://doi.org/10.47275/2692-093X-114
- Ma F., Hashmi A., Liu C.Y., et al. (2022) Cognitive Stressors and COVID-19 Infection: A Longitudinal Survey. Neurol Sci Neurosurg, Volume 3:1. 119. DOI: https://doi.org/10.47275/2692-093X-119
- Ma F., Cahn-Hidalgo D. (2021) Clinical Validation of Cognivue® – A Computerized Alternative to the Montreal Cognitive Assessment Test. Neurol Sci Neurosurg, Volume 2:2. 116. DOI: https://doi.org/10.47275/2692-093X-116
- Ma F., Hashmi A., Liu C.Y. (2020) COVID-19-Related Stressors and the Role of Cognitive Assessment, Neurol Sci Neurosurg, Volume 2:1. 115. DOI: https://doi.org/10.47275/2692-093X-115
- Bomprezzi R., Ararat K., Eleftheriou E. (2020) Cognitive Impairment in Patients with Multiple Sclerosis as Assessed by Objective Computerized Testing, Neurol Sci Neurosurg, Volume 2:1. 113. DOI: https://doi.org/10.47275/2692-093X-113.
- Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., Cooper, C., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Larson, E. B., Ritchie, K., Rockwood, K., Sampson, E. L., Samus, Q., … Mukadam, N. (2017). Dementia prevention, intervention, and care. Lancet (London, England), 390(10113), 2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6
- Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
- Lin, F. R., Yaffe, K., Xia, J., Xue, Q. L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., & Health ABC Study Group (2013). Hearing loss and cognitive decline in older adults. JAMA internal medicine, 173(4), 293–299. https://doi.org/10.1001/jamainternmed.2013.1868
- Fortunato, S., Forli, F., Guglielmi, V., De Corso, E., Paludetti, G., Berrettini, S., & Fetoni, A. R. (2016). A review of new insights on the association between hearing loss and cognitive decline in ageing. Acta otorhinolaryngologica Italica 36(3), 155–166. https://doi.org/10.14639/0392-100X-993
- Beck D.L., Grisel J.J. (2022) Cognitive screenings in otolaryngology? The time has come. J Otolaryngol ENT Res.14(2):56‒60. DOI: 10.15406/joentr.2022.14.00507
- Beck D.L. (2022) The emerging relationship between cognition and audition: why cognitive screenings are beneficial for audiology patients and why comprehensive audiometric evaluations are recommended for people with mild cognitive impairment, cognitive decline and dementia. J Otolaryngol ENT Res. 14(1):1‒6. DOI: 10.15406/joentr.2022.14.00496
- Beck D.L., Bant S., Clarke N.A. (2020) Hearing loss and cognition: a discussion for audiologists and hearing healthcare professionals. J Otolaryngol ENT Res. 12(3):72‒78. DOI: 10.15406/joentr.2020.12.00459
- Rawle, M. J., Cooper, R., Kuh, D., & Richards, M. (2018). Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. Journal of the American Geriatrics Society, 66(5), 916–923. https://doi.org/10.1111/jgs.15317
- Loggia, G., Attoh-Mensah, E., Pothier, K., Morello, R., Lescure, P., Bocca, M. L., Marcelli, C., & Chavoix, C. (2020). Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility. Frontiers in pharmacology, 10, 1659. https://doi.org/10.3389/fphar.2019.01659
- Vetrano, D. L., Villani, E. R., Grande, G., Giovannini, S., Cipriani, M. C., Manes-Gravina, E., Bernabei, R., & Onder, G. (2018). Association of Polypharmacy With 1-Year Trajectories of Cognitive and Physical Function in Nursing Home Residents: Results From a Multicenter European Study. Journal of the American Medical Directors Association, 19(8), 710–713. https://doi.org/10.1016/j.jamda.2018.04.008
- Langeard, A., Pothier, K., Morello, R., Lelong-Boulouard, V., Lescure, P., Bocca, M. L., Marcelli, C., Descatoire, P., & Chavoix, C. (2016). Polypharmacy Cut-Off for Gait and Cognitive Impairments. Frontiers in pharmacology, 7, 296. https://doi.org/10.3389/fphar.2016.00296
- American Psychological Association.2019 Phsychological and Neuropsychological Testing CPT® Codes, Descriptions & Total RVUs. Available:https://www.apaservices.org/practice/reimbursement/health-codes/psychological-neuropsychological-codes.pdf. Accessed May 16, 2019.
- Magellan Health, Inc. 2019 CPT® Coding Changes for Psychological and Neuropsychological Testing Background and Frequently Asked Questions. Available:https://www.magellanprovider.com/media/95403/psych-testing-coding-changes-faq.pdf. Accessed December 21, 2018
- MediCal Psychological Services. Allied Health – Psychological Services 519. December 2018. Available: https://files.medical.ca.gov/pubsdoco/publications/mastersmtp/part2/psychol_a07.doc. Accessed June 27, 2019.
- Tufts Health Plan. Medical Necessity Guidelines: Neuropsychological Testing and Assessment. January 2019. Available: https://tuftshealthplan.com/documents/providers/guidelines/medical-necessityguidelines/neuropsych-testing. Accessed June 27, 2019
- Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. The Lancet 2023; published online July 18. Available: https://doi.org/10.1016/S0140-6736(23)01406-X.
- Galvin JE, Velocity Clinical Research, et al. Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding Study (FOCUS). Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 16-20, 2023; Amsterdam.
- Abubaka A, Kabisatpathy S, Lutz S, Sinclair J. Community Pharmacists Expand Access to Cognitive Function Assessments with the Cognivue Clarity® Device. Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 16-20, 2023; Amsterdam.
- Galvin JE, Raskin J, et al. Advancing Computerized Cognitive Assessment with Cognivue: Enhanced Normative Range Data Sets from a Diverse Population Improve Sensitivity and Patient Profiling. Poster presented at: the Clinical Trials for Alzheimer’s Disease (CTAD) Annual Conference; October 24-27, 2023; Boston, MA.
- Montgomery B, et al. Comparing a Comprehensive Neuropsychological Battery Diagnosis to a Diagnosis Given by a Brief Computerized Assessment Tool. Poster presented at: the International Neuropsychological Society Meeting (INS); February 14-17, 2024; New York.
- Nicolas DM, et al. Correlation Between Learning and Memory Performance on a Computerized Cognitive Assessment and a Pencil-and-Paper Traditional Neuropsychological Measure. Poster presented at: the International Neuropsychological Society Meeting (INS); February 14-17, 2024; New York.
- Galvin JE, et al. Cognivue Clarity® in the Detection of Biomarker-Confirmed Mild Cognitive Impairment and Alzheimer’s Disease. Poster presented at: the American Academy of Neurology (AAN) Annual Meeting; April 13-18, 2024; Denver.
- Galvin JE, Chang LC, Estes PW, et al. Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population. J Alzheimers Dis. 2024;100(2):509-523. doi: 10.3233/JAD-240331. PMID: 38875043.
- Galvin JE, et al. Detection of Amyloid Status and Preclinical Alzheimer’s Disease Using Cognivue Clarity®, An Adaptive Psychophysics Computerized Cognitive Battery in The Bio-Hermes Study. Poster presented at: the Alzheimer’s Association International Conference (AAIC); July 28-August 1, 2024; Philadelphia.
- Livingston G, Huntley J, Liu K, et al. (2024). Dementia Prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 404(10452), 572-628. DOI: 10.1016/S0140-6736(24)01296-0.